← Eichor
Condition: Heart Failure Nyha Class Ii Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Heart Failure Nyha Class Ii

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

NORM-HF Pivotal Study
NA · 3 location(s) · Foundry Innovation & Research 1, Limited (FIRE1) · NCT07574593
Dietary Tracking in Heart Failure
Phase N/A · 1 location(s) · The Cleveland Clinic · NCT07649148
A Preventive, Multidisciplinary Primary Care Intervention Organized Around a Therapeutic Garden: Acceptability to Patien
NA · 1 location(s) · Assistance Publique Hopitaux De Marseille · NCT06646601
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
NA · 48 location(s) · Endotronix, Inc. · NCT05934487
Promoting Well-being and Health in Heart Failure
NA · 1 location(s) · Massachusetts General Hospital · NCT04829617
Atrial Appendage Micrograft Transplants to Assist Heart Repair After Cardiac Surgery
NA · 1 location(s) · Hospital District of Helsinki and Uusimaa · NCT05632432
Heart Failure Management for Patient With CIED Remotely Monitored
NA · 1 location(s) · Implicity · NCT07247032
Comprehensive Hybrid Cardiac Rehabilitation Trial on Heart Failure
NA · 4 location(s) · Universidad de La Frontera · NCT06313684
Baduanjin-eight-silken-movement With Self-efficacy Building for Patients With Chronic Heart Failure (BESMILE-HF Study)
NA · 1 location(s) · Guangdong Provincial Hospital of Traditional Chinese Medicin · NCT03180320
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.